illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. NIOX Group
Company logo

NIOX Group | Sustainability Performance

https://investors.niox.com
Linkedin

NIOX Group Plc focuses on developing medical devices and diagnostic solutions. The company specializes in respiratory health, offering products that aid in the management of asthma and other conditions.

2006

United Kingdom

51 - 200 employees

Biotechnology

$25M - 100M in revenue

$1M - 10M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#5178
Overall
#705
in United Kingdom
#77
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Digital emissions
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Silence Therapeutics

United Kingdom, Hospital & Health Care, Biotechnology

Company logo
Smith & Nephew

United Kingdom, Hospital & Health Care, Medical Device

Company logo
Kingsley Healthcare

United Kingdom, Hospital & Health Care, Hospital & Health Care

Market cap

22.7B $, 2026▼7.4% YoY

Revenue

54.0M $, 2024▲12.2% YoY

R&D intensity

4.88% 2024

Digital Emissions

CO2e per visit (g)

Industry benchmark

B/M 0.26 g
0.92 g
C
Environmental ScoreScore C
Green HostingYes
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • NIOX's asthma diagnostic devices faced product quality inquiries regarding calibration accuracy in clinical settings.
Powered by illuminem

Market cap

22.7B $, 2026▼7.4% YoY

Revenue

54.0M $, FY2024▲12.2% YoY

EBITDA

9.2M $, FY2024▼9.1% YoY

Operating margin

18% Industry: -370▲32.1% YoY

Revenue & EBITDA

$54.0MFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

21.3M 2024▲30.3% YoY

Capex

1.3M 2024▲100% YoY

Debt/equity ratio

0.0 Industry: 2▼NaN% YoY

R&D intensity

4.9%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

6.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 2.5%

2022

0.0

▼ 3.1%

2023

0.1

▼ 1.9%

2024

0.1

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

57%
Independent Directors

4 out of 7 incl. management

Powered by illuminem

Overall score

52

Environment

36

Social

66

Governance

54

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

Total sustainability employees

2-3

    Available in
    Scale package

    Access
  • Email
  • Email